TFXTeleflex Incorporated

$125.11+2.9% 1Y

Is the price fair?

Fair

The yardsticks disagree: cheap against its own 5-year P/E range (14th percentile) but the cash-flow math implies demanding growth. Treat as fair, not cheap.

1 good, 2 to watch
What the price assumes~+13% a year

Priced for ~13% a year FCF growth. The price already bakes in strong, sustained growth.

Vs its own P/E rangecheaper than 86% of its own historyderived

Cheap vs its own history: P/E 27.7 vs a 37.4 median over 36 quarters (−26% vs median).

Vs sector (EV/EBIT)183.1×

Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF yieldbehind 71% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What TFX's price assumes

Today's price asks for 13% free cash flow growth a year; over the last three years Teleflex Incorporated delivered −20%, the price is ahead of the record.

2.51

Price / sales · no P/E: the last twelve months did not end in a profit

Free cash flow yield
3.0%

Free cash flow yield · Medical Instruments & Supplies median 3.4%

Growth the price implies
+13%

Growth the price implies · The price pays for +13% free cash flow growth a year for a decade; the business has delivered −20% a year over the last three.

Price / book
1.95

Price / book · today's price, trailing year to Jun 30, 2026

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
1.95
EV / EBIToperating margin 2.0%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to Jun 30, 2026
3.61
Free cash flow, trailing twelve months
$168M
Market capitalisation
$5.66B
3-year revenue growth
−8.0%
3-year free cash flow growth
−20%

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.